Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: Results from the Barostim neo trial

导出原文传递

翻译打印收藏纠错

作者： Hoppe,U.C. ^[1] ; Brandt,M.-C. ^[2] ; Wachter,R. ^[3] ; Beige,J. ^[4] ; Rump,L.C. ^[5] ; Kroon,A.A. ^[6] ; Cates,A.W. ^[7] ; Lovett,E.G. ; Haller,H.

作者单位： Department of Cardiology, University of G?ttingen, G?ttingen, Germany ^[1] Department of Internal Medicine II, Paracelsus Medical University Salzburg, Müllner Hauptstr. 48, A ^[2] Department of Nephrology, University of Leipzig, Leipzig, Germany ^[3] CVRx, Inc., Minneapolis, MN, United States ^[4] Department of Nephrology, Medizinische Hochschule Hannover, Hannover, Germany ^[5] Department of Nephrology, University Hospital Düsseldorf, Düsseldorf, Germany ^[6] University Hospital Maastricht, Cardiovascular Research Institute Maastricht (CARIM), Maastricht ^[7]

关键词 Baroreflex Medical device Resistant hypertension

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交